The benign c.344G > A: p.(Arg115His) variant in the LDLR gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemia
Abstract Background We previously identified the c.344G > A: p.(Arg115His) variant in the low-density lipoprotein receptor (LDLR) gene, which was interpreted as “conflicting interpretations of pathogenicity” in ClinVar, based on a genetic analysis of patients with familial hypercholesterolemia (F...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-04-01
|
Series: | Lipids in Health and Disease |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12944-020-01252-4 |
id |
doaj-f882df5c9c6e461db4b0df137fb7393b |
---|---|
record_format |
Article |
spelling |
doaj-f882df5c9c6e461db4b0df137fb7393b2020-11-25T02:06:28ZengBMCLipids in Health and Disease1476-511X2020-04-011911510.1186/s12944-020-01252-4The benign c.344G > A: p.(Arg115His) variant in the LDLR gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemiaMika Hori0Atsushi Takahashi1Cheol Son2Masatsune Ogura3Mariko Harada-Shiba4Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research InstituteDepartment of Genomic Medicine, National Cerebral and Cardiovascular Center Research InstituteLaboratory of Clinical Genetics, National Cerebral and Cardiovascular CenterDepartment of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research InstituteDepartment of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research InstituteAbstract Background We previously identified the c.344G > A: p.(Arg115His) variant in the low-density lipoprotein receptor (LDLR) gene, which was interpreted as “conflicting interpretations of pathogenicity” in ClinVar, based on a genetic analysis of patients with familial hypercholesterolemia (FH). However, whether this variant affects the pathophysiology of FH remains unclear. Therefore, our aim was to annotate the c.344G > A: p.(Arg115His) variant in the LDLR gene in FH. We present 2 families harboring the c.344G > A: p.(Arg115His) variant in the LDLR gene. Methods Genetic analyses were performed for the coding regions and the exon-intron boundary sequence of the LDLR and proprotein convertase subtilisin/kexin type 9 (PCSK9) genes in 2 FH families. Next, the family without pathogenic variants in the LDLR and PCSK9 genes was screened by whole-exome sequencing. Detailed clinical and biochemical data were gathered from family members. Results In one family, the index case had biallelic c.1567G > A: p.(Val523Met) and c.344G > A: p.(Arg115His) variants in the LDLR gene, while the sibling had only the c.1567G > A: p.(Val523Met) variant in the LDLR gene. There was no difference in the FH phenotype between the siblings. In another family, the index case and the sibling had no pathogenic variants in the LDLR, PCSK9, and apolipoprotein B (APOB) genes, but the sibling’s wife with nonFH had the c.344G > A: p.(Arg115His) variant in the LDLR gene. The sibling and his wife had 4 children, including an unaffected child and an affected child who had the c.344G > A: p.(Arg115His) variant in the LDLR gene. In addition, the allele frequency of the c.344G > A: p.(Arg115His) variant (0.0023–0.0043) in Japanese and East Asian populations is relatively high compared with that of the other LDLR pathogenic variants (0.0001–0.0008). Conclusions The c.344G > A: p.(Arg115His) variant in the LDLR gene is interpreted as benign in individuals with FH.http://link.springer.com/article/10.1186/s12944-020-01252-4LDL receptorFamilial hypercholesterolemiaVariantBenignAnnotation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mika Hori Atsushi Takahashi Cheol Son Masatsune Ogura Mariko Harada-Shiba |
spellingShingle |
Mika Hori Atsushi Takahashi Cheol Son Masatsune Ogura Mariko Harada-Shiba The benign c.344G > A: p.(Arg115His) variant in the LDLR gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemia Lipids in Health and Disease LDL receptor Familial hypercholesterolemia Variant Benign Annotation |
author_facet |
Mika Hori Atsushi Takahashi Cheol Son Masatsune Ogura Mariko Harada-Shiba |
author_sort |
Mika Hori |
title |
The benign c.344G > A: p.(Arg115His) variant in the LDLR gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemia |
title_short |
The benign c.344G > A: p.(Arg115His) variant in the LDLR gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemia |
title_full |
The benign c.344G > A: p.(Arg115His) variant in the LDLR gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemia |
title_fullStr |
The benign c.344G > A: p.(Arg115His) variant in the LDLR gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemia |
title_full_unstemmed |
The benign c.344G > A: p.(Arg115His) variant in the LDLR gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemia |
title_sort |
benign c.344g > a: p.(arg115his) variant in the ldlr gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemia |
publisher |
BMC |
series |
Lipids in Health and Disease |
issn |
1476-511X |
publishDate |
2020-04-01 |
description |
Abstract Background We previously identified the c.344G > A: p.(Arg115His) variant in the low-density lipoprotein receptor (LDLR) gene, which was interpreted as “conflicting interpretations of pathogenicity” in ClinVar, based on a genetic analysis of patients with familial hypercholesterolemia (FH). However, whether this variant affects the pathophysiology of FH remains unclear. Therefore, our aim was to annotate the c.344G > A: p.(Arg115His) variant in the LDLR gene in FH. We present 2 families harboring the c.344G > A: p.(Arg115His) variant in the LDLR gene. Methods Genetic analyses were performed for the coding regions and the exon-intron boundary sequence of the LDLR and proprotein convertase subtilisin/kexin type 9 (PCSK9) genes in 2 FH families. Next, the family without pathogenic variants in the LDLR and PCSK9 genes was screened by whole-exome sequencing. Detailed clinical and biochemical data were gathered from family members. Results In one family, the index case had biallelic c.1567G > A: p.(Val523Met) and c.344G > A: p.(Arg115His) variants in the LDLR gene, while the sibling had only the c.1567G > A: p.(Val523Met) variant in the LDLR gene. There was no difference in the FH phenotype between the siblings. In another family, the index case and the sibling had no pathogenic variants in the LDLR, PCSK9, and apolipoprotein B (APOB) genes, but the sibling’s wife with nonFH had the c.344G > A: p.(Arg115His) variant in the LDLR gene. The sibling and his wife had 4 children, including an unaffected child and an affected child who had the c.344G > A: p.(Arg115His) variant in the LDLR gene. In addition, the allele frequency of the c.344G > A: p.(Arg115His) variant (0.0023–0.0043) in Japanese and East Asian populations is relatively high compared with that of the other LDLR pathogenic variants (0.0001–0.0008). Conclusions The c.344G > A: p.(Arg115His) variant in the LDLR gene is interpreted as benign in individuals with FH. |
topic |
LDL receptor Familial hypercholesterolemia Variant Benign Annotation |
url |
http://link.springer.com/article/10.1186/s12944-020-01252-4 |
work_keys_str_mv |
AT mikahori thebenignc344gaparg115hisvariantintheldlrgeneinterpretedfromapedigreebasedgeneticanalysisoffamilialhypercholesterolemia AT atsushitakahashi thebenignc344gaparg115hisvariantintheldlrgeneinterpretedfromapedigreebasedgeneticanalysisoffamilialhypercholesterolemia AT cheolson thebenignc344gaparg115hisvariantintheldlrgeneinterpretedfromapedigreebasedgeneticanalysisoffamilialhypercholesterolemia AT masatsuneogura thebenignc344gaparg115hisvariantintheldlrgeneinterpretedfromapedigreebasedgeneticanalysisoffamilialhypercholesterolemia AT marikoharadashiba thebenignc344gaparg115hisvariantintheldlrgeneinterpretedfromapedigreebasedgeneticanalysisoffamilialhypercholesterolemia AT mikahori benignc344gaparg115hisvariantintheldlrgeneinterpretedfromapedigreebasedgeneticanalysisoffamilialhypercholesterolemia AT atsushitakahashi benignc344gaparg115hisvariantintheldlrgeneinterpretedfromapedigreebasedgeneticanalysisoffamilialhypercholesterolemia AT cheolson benignc344gaparg115hisvariantintheldlrgeneinterpretedfromapedigreebasedgeneticanalysisoffamilialhypercholesterolemia AT masatsuneogura benignc344gaparg115hisvariantintheldlrgeneinterpretedfromapedigreebasedgeneticanalysisoffamilialhypercholesterolemia AT marikoharadashiba benignc344gaparg115hisvariantintheldlrgeneinterpretedfromapedigreebasedgeneticanalysisoffamilialhypercholesterolemia |
_version_ |
1724933800379547648 |